The Paper Trail Behind TCRT's +512% Run: 8-Ks, ATMs and a 1.8-Month Runway

TLDR

• TCRT surged +512% for the entire move ($0.72 on Oct 6 to $4.40 on Oct 14) and +167% close-to-close ($0.80 -> $2.15, Oct 9 to Oct 15) after the Oct 13 announcement that Alaunos Therapeutics acquired Velaris Therapeutics, filed alongside an 8-K the same day. The tradeable float is 2,810,000 shares.
• Market cap sits at $3,100,000 with enterprise value of $2,700,000. On Oct 13 the stock traded 256,812,156 shares, so the float turned over many times in one session.
• The company reports current cash of $400,000 against a quarterly burn of $-670,000, which works out to 1.8 months of runway. That puts TCRT in imminent dilution risk territory.
• The filings that set up the run: an 8-K (Sept 17), a Registered Direct Offering priced at-the-market under Nasdaq rules (Sept 18), a 424B3 (Sept 21), an 8-K (Sept 22), Form 4 insider filings (Oct 8), an 8-K (Oct 9), then the acquisition 8-K (Oct 13).
• Trade math: a $10,000 position from $0.72 to $4.40 made $51,200 (+512%). Trading only the Oct 13 regular session, from the $1.73 open to the $3.03 close, made $7,510 (+75.1%). On Oct 14 the stock gave back -43.5% from open to close.

What Did TCRT's Filings Show Before the +512% Run?

Anyone reading TCRT's filings had two warnings before the price moved: the company had raised capital through a Registered Direct Offering on Sept 18, and it filed a fresh 8-K on Oct 9, two sessions before volume exploded. Both pointed to a cash-constrained biotech with corporate action pending. Alaunos Therapeutics (Nasdaq, Pharmaceutical Preparations) filed 18 SEC documents in the 90 days before this article. Four were 8-Ks, and all four came between Sept 17 and Oct 13.

The balance sheet is what made the setup. With $400,000 in current cash against a $3,100,000 market cap and 1.8 months of runway, the company needed a transaction, a raise, or both. A company with 12+ months of runway can sit still. TCRT could not, and its filing calendar shows it.

The reported short interest is 0.2% and institutional ownership is 2.7%. This was not a squeeze of crowded shorts. It was a supply squeeze: 2,810,000 tradeable shares, a catalyst headline, and 256,812,156 shares of demand in one session.

The Filing Timeline: September 17 to October 15

The TCRT filing chain runs in three phases: capital raise (Sept 17-22), insider and corporate disclosure (Oct 8-9), and the catalyst plus new-holder disclosures (Oct 13-15). Here is every dated filing and catalyst from the 90-day window in order.

Sept 17-22 is the textbook small-cap financing sequence: 8-K, offering pricing, prospectus supplement, follow-up 8-K. The Oct 8-9 cluster is quieter: insider Form 4s and an 8-K while the stock traded 87,035 and 52,218 shares on those two days. That low-volume, active-filing window is the forensic tell. Paperwork was moving while price sat still.

The Oct 15 Schedule 13D, Schedule 13D/A and Form 3 matter for the next leg. A Schedule 13D means a holder crossed a beneficial-ownership threshold with intent beyond passive investment. A Form 3 is the first filing by a new insider. Both landed two days after the acquisition announcement, so the ownership structure changed alongside the deal.

What Each Filing Type Means for TCRT

Each form type in TCRT's chain tells you something different about supply. Reading them in order shows when new shares can hit the tape. A refresher calibrated to this ticker:

• 8-K: a material-event disclosure. Four in under a month from a $3,100,000 company signals transaction activity. The Oct 13 8-K came with the Velaris acquisition headline.
• 424B3: a prospectus supplement for securities already covered by an effective registration statement, commonly used for resale registrations. The Sept 21 filing followed the Sept 18 offering pricing by three days.
• 424B5: the pricing supplement for a shelf takedown, meaning an offering is live. TCRT did not file a 424B5 in the 90-day window. Market-wide, 13 424B5 filings came from 12 unique tickers in the past 3 days, including WFF, which priced an $18 Million Registered Direct Offering on Oct 14.
• S-3 / shelf registration: TCRT's active August 2025 Shelf has $772,676 remaining, with a baby shelf restriction where the price must exceed $26.68 before that limit lifts. Market-wide, 9 S-3 filings came from 9 unique tickers in the past 3 days.
• Form 4 / Form 3 / Schedule 13D: insider and ownership disclosures. TCRT's Form 4s on Oct 8 came before the run. The Form 3 and 13D filings on Oct 15 came after it.

For a longer breakdown of how shelf takedowns turn into live supply, see the GRML 424B5 and shelf forensic breakdown and the OLB ATM suspension and S-1 paper trail.

Share Structure Impact: Active vs Completed Facilities

TCRT has 7 active dilution facilities and 3 completed or historical ones. The active list includes two ATMs, a warrant tranche, two convertible preferred series, an equity line and a shelf. Only the active list is a current dilution threat. The completed ones are capital that has already been raised.

Three things in this table matter to a trader:

1. The conversion and strike prices were crossed during the run. The April 2025 Convertible Preferred converts at $2.76. TCRT closed the Oct 13 regular session at $3.03, above that level. The May 2025 Warrant strike of $4.0 sat below the $4.40 high of day on Oct 14. Holders of those instruments had in-the-money paper at the peak.
2. The equity line is larger than the company. The May 2025 Mast Hill SPA has $25,000,000 remaining against a $3,100,000 market cap. Equity lines let the company sell shares to the counterparty over time, and a high-volume tape is when that capacity is easiest to use.
3. The shelf is capped. The August 2025 Shelf has $772,676 remaining and a baby shelf threshold of $26.68. At $2-$4 share prices the baby shelf rules bind, so shelf capacity is small compared with the ATM and equity-line capacity.

The dossier also lists 8 completed offerings on file for TCRT. That includes the Sept 18 Registered Direct Offering, which is a closed raise and not an overhang.

For context across the small-cap universe, there are ~6,200 active warrant facilities, ~3,200 active shelves, ~2,200 active ATM programs, ~900 active convertible preferred facilities and ~600 active equity lines. TCRT carries all four of those active types at once on a 2,810,000-share float.

Price Action Context: Session-by-Session

TCRT went from 52,218 shares on Oct 9 to 256,812,156 shares on Oct 13. The move ran in two days and partly reversed on the third. Here is every session from the dossier, using regular-session open and close, with pre-market and after-hours shown separately.

Last Week (Oct 05-Oct 09): The Quiet Base

Last week TCRT traded between $0.74 and $0.84 at the regular-session close, and volume never reached 400,000 shares. The full-move low of $0.72 printed on Oct 6. The Oct 8 Form 4s and Oct 9 8-K were filed during this window, and the Oct 9 regular session opened and closed at $0.80, the flattest print in the data.

This Week So Far (Oct 12-Oct 15): Ignition, Expansion, Reversal

Oct 12 was the ignition day. Volume jumped to 3,399,101 shares and the regular session closed +35.4% at $1.05, with no press release in the news feed that day. That was a volume-led move before the headline.

Oct 13 was the catalyst day. The Velaris acquisition announcement and 8-K hit, pre-market went from $1.00 to $1.73, and the regular session ran from $1.73 to $3.03 on 256,812,156 shares. After-hours then added more, from $3.04 to $3.89.

Oct 14 was the reversal. Pre-market opened at $3.63, the regular session opened at $3.68, and the $4.40 high of day printed in the first fifteen minutes (13:45 UTC bar). From there the stock bled to a $2.08 close, -43.5% from the open, on 68,537,489 shares. On Oct 15 it held: $2.03 open, $2.15 close, then an after-hours run from $2.18 to $2.85.

How Could You Have Caught TCRT Before It Ran?

The earliest actionable signal was the filing calendar combined with the cash number. A $400,000 cash balance, 1.8 months of runway and four 8-Ks in four weeks marked TCRT as a company with a transaction coming. Here is the sequence a filing-first trader would have seen:

1. Sept 17-22, the raise. The 8-K, offering pricing, 424B3 and follow-up 8-K showed the company was actively financing. That put TCRT on a dilution-and-catalyst watchlist.
2. Oct 8-9, paper moving while price sits still. Multiple Form 4 filings on Oct 8 and an 8-K on Oct 9, while daily volume ran 87,035 and 52,218 shares. Filing activity running far ahead of volume is the setup.
3. Oct 12 pre-market, the first volume trigger. The pre-market opened at $0.70 and volume for the day reached 3,399,101 shares, a large jump from the prior session. An RVOL filter would have flagged this before any headline.
4. Oct 13 pre-market, the catalyst. The acquisition headline plus the 8-K, with pre-market moving from $1.00 to $1.73. By the regular open the trade was obvious, but the tape had been warning since Oct 12.

This matches the ignition sequence covered in the pre-market high ignition framework: an early volume day, a catalyst morning, then a pre-market high that holds as support at the open.

The Opportunity and the Risk

TCRT is both sides of the dilution trade on one chart. The opportunity was a sub-$1 stock with a 2,810,000-share float meeting a real catalyst headline. The risk is a company with 1.8 months of runway and an active ATM, equity line, shelf, warrants and convertible preferred, all of which can add supply into strength.

The opportunity, in dollars. A $10,000 position from the $0.72 low to the $4.40 high returned $51,200 (+512%). Nobody captured that exactly. The more realistic catalyst-day trade, from the Oct 13 regular open at $1.73 to the $3.03 close, captured $7,510 (+75.1%). The close-to-close hold from $0.80 to $2.15 returned $16,740 (+167.4%).

The risk, in filings. The cash framing is clear: $400,000 of current cash and $-670,000 of quarterly burn. The company needs capital, and the active facilities show where it can come from:

• Two ATMs with $1,074,945 remaining each (Piper Sandler and Jefferies). ATM sales go straight into the open market at current prices.
• The May 2025 Mast Hill SPA equity line with $25,000,000 remaining.
• Convertible preferred at $2.76 and $4.49, and 79,900 warrants at $4.0, all near or below the prices the stock hit during the run.

The Oct 14 tape shows supply arriving: a $4.40 high in the first fifteen minutes, then -43.5% from open to close on 68,537,489 shares. Which facility was used on Oct 14 is not disclosed in the available data, so this article does not attribute the selling to any one of them. The mechanics are the point. Every active facility above has terms that pay out more when the stock is higher.

The pre-offering run angle. Cash-constrained companies with live ATMs and equity lines benefit from raising at higher prices. That is why high-volume catalyst days in these names attract both momentum buyers and supply. The run is tradeable. Holding through it on the assumption that the company will not sell is the mistake.

How TCRT Compares to This Week's Other Runners

TCRT led the week's multi-day runners at +167.4% close-to-close, ahead of JBDI at +145.3% and BMBL at +131.5%. The comparison set shows how differently dilution paper plays out.

WFF is the cautionary counterpart. It ran +483.2% in the regular session on Oct 9 (covered in the October 9 data digest), announced an $18 Million Registered Direct Offering on Oct 14, and closed the regular session down 90.4% that day at $0.18. NWGL fell 78.0% in the regular session on Oct 14, and the US$200 Million ATM program announcement followed on Oct 15. TCRT's -43.5% on Oct 14 was severe, but the stock held $2.03-$2.15 the next day. The difference on paper is that TCRT's catalyst was an acquisition, while WFF's and NWGL's were offerings.

The backdrop worked against everyone. The Russell 2000 (IWM) sits at $275.08, -9.9% from its 52-week high of $305.18 and -3.6% over 20 days. The macro call is Risk-Off / Consolidation. The S&P 500 (SPY) is at $771.79, -1.3% from its 52-week high. When small caps lag like this, multi-day runners give back gains fast. For the sector view, see the JBDI and Financial Services rotation playbook.

How to Play This

The framework for setups like TCRT: trade the catalyst session, respect the dilution facilities, and treat the day after a 100M+ share session as a supply test, not a continuation. Specifics:

• Entry zone: On a catalyst morning, the pre-market close is the reference level. On Oct 13 the pre-market closed at $1.73 and the regular session opened at the same price. Holding above that level at the open was the long trigger. Losing it would have been the exit.
• Know the conversion prices before you enter. On TCRT, $2.76 (convertible preferred), $4.0 (warrant strike) and $4.49 (Series A-2 conversion) are the levels where paper holders profit. Treat them as supply zones.
• Day 2 after a 100M+ share session: Oct 14 opened at $3.68, printed $4.40 within fifteen minutes, then closed at $2.08. The opening push is a fade setup for experienced traders. For longs, take profits into the push rather than adding.
• Size for Risk-Off. With IWM -3.6% over 20 days, cut size and tighten stops. Multi-day holds in cash-constrained names during a Risk-Off backdrop carry offering risk on top of tape risk.
• Track MFE capture. The gap between the $51,200 full-move number and the $7,510 catalyst-day number is what your execution is worth. Log both in the trading journal. AI Insights flags your MFE capture rate and the time of day you give back gains.

How to Find These Setups

You find setups like TCRT by combining a filing screen with a volume trigger: look for cash-constrained small caps with recent 8-K activity, then wait for RVOL to confirm. Here is how to build it in SNACS.

Scanner filters. In the SNACS scanner, filter for price $0.50-$5, float under 5M shares, and cash runway under 6 months. Add the Dilution Alerts column and sort by RVOL. TCRT's Oct 12 volume jump from 52,218 to 3,399,101 shares would have pushed it up an RVOL-sorted list during that session. Save the filter as a named scan and link it to a Dynamic Watchlist, so new matches populate automatically and show a colored square in the main stream.

Ticker details page. Click any ticker to open the ticker details page. The dilution risk panel shows active shelf, ATM and warrant facilities, including the $1,074,945 ATM balances and the $4.0 warrant strike on TCRT, next to recent news and SEC Filings. You can check the overhang without leaving the scanner.

SEC research. In SEC research, the Dilution Snapshot lists active facility counts, the lowest exercise price and the baby shelf threshold ($26.68 for TCRT's August 2025 Shelf). The Filing Browser lets you filter SEC Filings by category, so you can pull every 8-K, 424B3 and Form 4 for a ticker in date order and rebuild the timeline above. The AI Chat answers questions like 'What is TCRT's cash runway and which facilities are active?' straight from the filings.

Playbook live matching. Build a playbook in the AI Playbook Builder with these steps: historical context (sub-$1, float under 5M), setup (8-K filed within 5 days), trigger (volume spike), entry (pre-market close held at the open). When a ticker matches, a star appears in the scanner.

Data API. If you run your own AI workflow, the Data API and MCP server give Claude, Cursor or a script the same float, cash and dilution facility data, with the source filing for each number. You can backtest filing-plus-volume setups with point-in-time queries and no lookahead.

Market-wide, the past 3 days produced 307 8-K filings from 280 unique tickers, 22 424B3 filings from 14 unique tickers, and 13 424B5 filings from 12 unique tickers. Filtering that flow for low runway and small float is how you cut it down to names like TCRT.

What to Watch Next

On TCRT, watch for a new 8-K, a 424B5, or any filing that references the ATMs or the Mast Hill SPA. With 1.8 months of runway, the company's capital needs did not change because the stock ran. Key levels from the data: the $2.03 regular-session open on Oct 15, the $2.76 convertible preferred conversion price, and the $2.85 after-hours close on Oct 15. A regular session holding above $2.76 puts that convertible preferred in the money again.

Across the tape, stocks trading 100M+ shares fired 24 times this week against a 90-day weekly average of 30.3, while total scanner pattern activity hit 184 against a 90-day weekly average of 167.3. Activity is above average while IWM sits -9.9% from its high. Expect fast moves that fade fast. Watch Friday's tape: the last 4 Fridays averaged a 228.1% top gain, and last Friday's leader was WFF.

FAQ

Why did TCRT stock go up +512%?

TCRT ran +512% from $0.72 on Oct 6 to $4.40 on Oct 14 after Alaunos Therapeutics announced its acquisition of Velaris Therapeutics on Oct 13, filed with an 8-K the same day. The 2,810,000-share float met 256,812,156 shares of volume on the catalyst day, a pure supply squeeze, with short interest at only 0.2%.

Is TCRT at risk of dilution?

Yes. TCRT reports $400,000 of current cash, a quarterly burn of $-670,000 and 1.8 months of runway, so dilution risk is imminent. It has 7 active facilities, including two ATMs with $1,074,945 remaining each, a $25,000,000 equity line, 79,900 warrants at $4.0 and convertible preferred at $2.76 and $4.49.

What SEC filings came before TCRT's run?

The chain was: an 8-K (Sept 17), a Registered Direct Offering priced at-the-market under Nasdaq rules (Sept 18), a 424B3 (Sept 21), an 8-K (Sept 22), Form 4 insider filings (Oct 8), an 8-K (Oct 9), and the acquisition 8-K (Oct 13). A Form 3, Schedule 13D and Schedule 13D/A followed on Oct 15.

What is the difference between a 424B3 and a 424B5?

A 424B3 is a prospectus supplement for securities already covered by an effective registration, commonly used for resale registrations. A 424B5 is the pricing supplement for a shelf takedown, which means an offering is live. TCRT filed a 424B3 on Sept 21 and no 424B5 in the 90-day window.

What does the baby shelf restriction mean for TCRT?

The baby shelf rule caps how much a small company can raise from its shelf until the stock trades above a set threshold. For TCRT's August 2025 Shelf that threshold is $26.68, and $772,676 of capacity remains. At current prices, TCRT's larger funding sources are the ATMs and the equity line, not the shelf.

How do I find stocks like TCRT before they run?

Screen for float under 5M, cash runway under 6 months and an 8-K filed in the last few days, then sort by RVOL. In SNACS, save that as a scan linked to a Dynamic Watchlist, open the ticker details page to check active dilution facilities, and use SEC research to rebuild the filing timeline.

Why did TCRT drop -43.5% on October 14?

On Oct 14 TCRT opened at $3.68, printed its $4.40 high of day within fifteen minutes, then closed at $2.08, a -43.5% drop from the open on 68,537,489 shares. Supply overwhelmed demand on day two of a 100M+ share move, with warrant and convertible preferred holders in the money and active ATM and equity-line capacity on file.